Suzhou Zelgen Biopharmaceuticals Co.,Ltd. (SHA:688266)
China
· Delayed Price · Currency is CNY 82.07
-1.09 (-1.31%)
Feb 28, 2025, 3:00 PM CST
SHA:688266 Revenue
In the year 2024, Suzhou Zelgen Biopharmaceuticals had annual revenue of 533.91M CNY with 38.16% growth. Suzhou Zelgen Biopharmaceuticals had revenue of 149.79M in the quarter ending December 31, 2024, with 43.57% growth.
Revenue
533.91M
Revenue Growth
+38.16%
P/S Ratio
41.06
Revenue / Employee
615.81K
Employees
867
Market Cap
21.72B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| Jiangsu Hengrui Medicine | 26.00B |
| WuXi AppTec | 38.50B |
| Aier Eye Hospital Group | 20.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Sichuan Biokin Pharmaceutical | 5.85B |